Role of phenylalanine 20 in Alzheimer's amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity

Chemical Research in Toxicology

Volumn 17, Issue 12, 2004, Pages 1743-1749

  Boyd Kimball, Debra ^a   Abdul, Hafiz Mohmmad ^a   Reed, Tanea ^a   Sultana, Rukhsana ^a   Butterfield, D Allan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN[1-42]; COPPER; METHIONINE; PHENYLALANINE;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL STRUCTURE; ELECTRON TRANSPORT; FETUS; LIPID PEROXIDATION; MITOCHONDRION; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PREDICTION; RAT; RAT STRAIN; SENILE PLAQUE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID; AMYLOID BETA-PROTEIN; ANIMALS; CELL CULTURE TECHNIQUES; COPPER; FEMALE; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHENYLALANINE; POINT MUTATION; PREGNANCY; RATS; TIME FACTORS;

ANIMALIA;

EID: 10844269704     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx049796w     Document Type: Article

References (38)

1. Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksnov, M., Aksenova, M., Gabbita, P., Wu, J. F., Carney, J. M., Lovell, M., Markebery, W. R., and Butterfield, D. A. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
2. Butterfield, D. A., and Lauderback, C. M. (2002) Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radical Biol. Med. 32, 1050-1060.
3. Butterfield, D. A., Drake, J., Pocernich, C., and Castegna, A. (2001) Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends Mol. Med. 7, 548-554.
4. Butterfield, D. A. (2002) Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radical Res. 36, 1307-1313.
5. Butterfield, D. A. (2003) Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: Mechanisms and consequences. Curr. Med. Chem. 10, 2651-2659.
6. Yatin, S. M., Varadarajan, S., and Butterfield, D. A. (2000) Vitamin E prevents Alzheimer's amyloid β-peptide (1-42)-induced neuronal protein oxidation and reactive oxygen species production. J. Alzheimer's Dis. 2, 123-131.
7. Yatin, S. M., Varadarajan, S., Link, C. D., and Butterfield, D. A. (1999a) In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42). Neurobiol. Aging 20, 325-330.
8. Drake, J., Link, C. D., and Butterfield, D. A. (2003) Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiol. Aging 24, 415-420.
9. Yatin, S. M., Yatin, M., Aulick, T., Ain, K. B., and Butter-field, D. A. (1999b) Alzheimer's amyloid β-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: Protective effect of vitamin E. Neurosci. Lett. 263, 17-20.
10. Selkoe, D. J. (2001) Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J. Alzheimer's Dis. 3, 75-80.
11. Varadarajan, S., Yatin, S., Aksenova, M., and Butterfield, D. A. (2000) Review: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity. J. Struct. Biol. 130, 184-208.
12. Kirkitadze, M. D., Bitan, G., and Teplow, D. B. (2002) Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies. J. Neurosci. Res. 69, 567-577.
13. Pike, C. J., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. (1991) Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures. Eur. J. Pharmacol.-Mol. Pharmacol. Sect. 207, 367-368.
14. Butterfield, D. A., and Kanski, J. (2002) Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid β-peptide 1-42. Peptides 23, 1299-1309.
15. Varadarajan, S., Yatin, S., Kanski, J., Jahanshahi, F., and Butterfield, D. A. (1999) Methionine residue 35 is important in amyloid β-peptide- associated free radical oxidative stress. Brain Res. Bull. 50, 133-141.
16. Pogocki, D. (2003) Alzheimer's β-amyloid peptide as a source of neurotoxic free radicals: The role of structural effects. Acta Neurobiol. Exp. 63, 131-145.
17. 35 in neurotoxic β-amyloid peptide. A molecular modeling study. Chem. Res. Toxicol. 15, 408-418.
18. Schöneich, C. (2002) Redox processes of methionine relevant to β-amyloid oxidation and Alzheimer's disease. Arch. Biochem. Biophys. 397, 370-376.
19. Bush, A. I. (2003) The metallobiology of Alzheimer's disease. Trends Neurosci. 26, 207-214.
20. Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., Tanzi, R. E., and Bush, A. I. (1999a) The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38, 7609-7616.
21. Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D. A., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Saunders, A. J., Lim, J., Moir, R. D., Glabe, C., Bowden, E. F., Masters, C. L., Fairlie, D. P., Tanzi, R. E., and Bush, A. I. (1999b) Cu(II) Potentiation of Alzheimer's Aβ neurotoxicity. J. Biol. Chem. 274, 37111-37116.
22. Curtain, C. C., Ali, F., Volitakis, I., Cherny, R. A., Norton, R. S., Beyreuther, K., Barrow, C. J., Masters, C. L., Bush, A. I., and Barnham, K. J. (2001) Alzheimer's disease amyloid-β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J. Biol. Chem. 276, 20466-20473.
23. Kowalik-Jankowska, T., Ruta-Dolejsz, M., Wisniewska, K., Lankiewicz, L., and Kozlowski, H. (2002) Possible involvement of copper(II) in Alzheimer's disease. Environ. Health Perspect. 110 (S5), 869-870.
24. Opazo, C., Huang, X., Cherny, R. A., Moir, R. D., Roher, A. E., White, A. R., Cappai, R., Masters, C. L., Tanzi, R. E., Inestrosa, N. C., and Bush, A. I. (2002) Metalloenzyme-like activity of Alzheimer's disease β-amyloid. J. Biol. Chem. 277, 40302-40308.
25. Pogocki, D. (2004) Mutation of the Phe(20) residue in Alzheimer's amyloid β-peptide might decrease its toxicity due to disruption of the Met(35)-cupric site electron transfer pathway. Chem. Res. Toxicol. 17, 325-329.
26. Grima, G., Benz, B., Parpura, V., Cuenod, M., and Do, K. Q. (2003) Dopamine-induced oxidative stress in neurons with glutathione deficit: Implication for schizophrenia. Schizophr. Res. 62, 213-224.
27. Ricart, K. C., and Fiszman, M. L. (2001) Hydrogen peroxide-induced neurotoxicity in cultured cortical cells grown in serum-free and serum-containing media. Neurochem. Res. 26, 801-808.
28. LeVine, H., III (1999) Quantification of β-sheet amyloid fibril structure with thioflavin T. Methods Enzymol. 309, 274-284.
29. Darzynkiewicz, Z., Li, X., and Gong, J. (1994) Assays of cell viability: Discrimination of cells dying by apoptosis. Methods Cell. Biol. 41, 15-38.
30. Behl, C. (1999) Vitamin E and other antioxidants in neuroprotection. Int. J. Vitam. Nutr. Res. 69 (3), 213-219.
31. Kanski, J., Aksenova, M., and Butterfield, D. A. (2002a) The hydrophobic environment of Met35 of Alzheimer's Aβ(1-42) is important for the neurotoxic and oxidative properties of the peptide. Neurotoxicol. Res. 4, 219-223.
32. Kanski, J., Aksenova, M., Schöneich, C., and Butterfield, D. A. (2002b) Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative and neurotoxic properties of Alzheimer's amyloid β-peptide. Free Radical Biol. Med. 32, 1205-1211.
33. Kanski, J., Varadarajan, S., Aksenova, M., and Butterfield, D. A. (2001) Role of glycine-33 and methionine-35 in Alzheimer's amyloid β-peptide 1-42-associated oxidative stress and neurotoxicity. Biochim. Biophys. Acta 7586, 190-198.
34. Schöneich, C., Pogocki, D., Hug, G. L., and Bobrowski, K. (2003) Free Radical reactions of methionine in peptides: Mechanisms relevant to β-amyloid oxidation and Alzheimer's disease. J. Am. Chem. Soc. 125, 13700-13713.
35. Rauk, A., Armstrong, D. A., and Fairlie, D. P. (2000) Is oxidative damage by β-amyloid and prion peptides mediated by hydrogen atom transfer from glycine α-carbon to methionine sulfur with β-sheets? J. Am. Chem. Soc. 122, 9761-9767.
36. Brunelle, P., and Rauk, A. (2002) The radical model of Alzheimer's disease: Specific recognition of Gly29 and Gly33 by Met35 in a β-sheet model of Aβ: An ONIOM study. Alzheimer's Dis. 4, 283-289.
37. Butterfield, D. A., and Bush, A. I. (2004) Alzheimer's amyloid β-peptide (1-42): Involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide. Neurobiol. Aging 25, 563-568.
38. Hou, L., Shao, H., Zhang, Y., Li, H., Menon, N. K., Neuhaus, E. B., Brewer, J. M., Byeon, I. L., Ray, D. G., Vitek, M. P., Iwashita, T., Makula, R. A., Prybyla, A. B., and Zagorski, M. G. (2004) Solution NMR studies of Aβ(1-40) and Aβ(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation. J. Am. Chem. Soc. 126, 1992-2005.